RAD51C deletion screening identifies a recurrent gross deletion in breast cancer and ovarian cancer families

Breast Cancer Research

Volumn 15, Issue 6, 2013, Pages

  Schnurbein, Gioia ^a   Hauke, Jan ^a   Wappenschmidt, Barbara ^a   Weber Lassalle, Nana ^a   Engert, Stefanie ^b   Hellebrand, Heide ^b   Garbes, Lutz ^c   Becker, Alexandra ^a   Neidhardt, Guido ^a   Rhiem, Kerstin ^a   Meindl, Alfons ^b   Schmutzler, Rita K ^a   Hahnen, Eric ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST CARCINOMA; CANCER FAMILY; CANCER GRADING; CANCER LOCALIZATION; DIZYGOTIC TWINS; EXON; GENE; GENE DELETION; GENE REARRANGEMENT; GENETIC SCREENING; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HEREDITY; HUMAN; LETTER; MUTATION RATE; OVARY CANCER; POLYMERASE CHAIN REACTION; RAD51C GENE; TRIPLE NEGATIVE BREAST CANCER; ADULT; BREAST TUMOR; FEMALE; GENETICS; OVARY TUMOR; PEDIGREE;

RAD51 PROTEIN; RAD51 PROTEIN, HUMAN;

ADULT; BREAST NEOPLASMS; FEMALE; GENE DELETION; HUMANS; OVARIAN NEOPLASMS; PEDIGREE; RAD51 RECOMBINASE;

EID: 84890685811     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr3589     Document Type: Letter

References (6)

1. Meindl A, Hellebrand H, Wiek C, Erven V, Wappenschmidt B, Niederacher D, Freund M, Lichtner P, Hartmann L, Schaal H, Ramser J, Honisch E, Kubisch C, Wichmann HE, Kast K, Deissler H, Engel C, Müller-Myhsok B, Neveling K, Kiechle M, Mathew CG, Schindler D, Schmutzler RK, Hanenberg H. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet 2010, 42:410-414. 10.1038/ng.569, 20400964.
2. Loveday C, Turnbull C, Ruark E, Xicola RM, Ramsay E, Hughes D, Warren-Perry M, Snape K, Evans DG ED, Gore M, Renwick A, Seal S, Antoniou AC, Rahman N,. Breast Cancer Susceptibility Collaoration (UK) Germline RAD51C mutations confer susceptibility to ovarian cancer. Nat Genet 2012, 44:475-476. author reply 476, 10.1038/ng.2224, 22538716, Breast Cancer Susceptibility Collaoration (UK).
3. Pelttari LM, Heikkinen T, Thompson D, Kallioniemi A, Schleutker J, Holli K, Blomqvist C, Aittomaki K, Butzow R, Nevanlinna H. RAD51C is a susceptibility gene for ovarian cancer. Hum Mol Genet 2011, 20:3278-3288. 10.1093/hmg/ddr229, 21616938.
4. Thompson ER, Boyle SE, Johnson J, Ryland GL, Sawyer S, Choong DY, ConFab K, Chenevix-Trench G, Trainer AH, Lindeman GJ, Mitchell G, James PA, Campbell IG. Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients. Hum Mutat 2012, 33:95-99. 10.1002/humu.21625, 21990120.
5. Stevens KN, Vachon CM, Couch FJ. Genetic susceptibility to triple-negative breast cancer. Cancer Res 2013, 73:2025-2030. 10.1158/0008-5472.CAN-12-1699, 23536562.
6. Wappenschmidt B, Becker AA, Hauke J, Weber U, Engert S, Köhler J, Kast K, Arnold N, Rhiem K, Hahnen E, Meindl A, Schmutzler RK. Analysis of 30 putative BRCA1 splicing mutations in hereditary breast and ovarian cancer families identifies exonic splice site mutations that escape in silico prediction. PLoS One 2012, 7:e50800. 10.1371/journal.pone.0050800, 3519833, 23239986.